MarketInOut Stock Screener Log In | Sign Up
 

Pulse Biosciences Inc

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/23/2026
Pulse Biosciences Inc stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,781.52 mln
Float21.05 mln
Earnings Date11/16/2026

Piotroski F-Score

4 / 9
Borderline

1-Year Forecast

62.33
Attractive

Relative Strength

51 / 100
In line with market

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-6,756%
Severely loss-making

ROE

-90.23
Deeply negative

Business Description

Pulse Biosciences is a medical technology company founded in 2014 and based in Miami, Florida. The company develops energy-based treatment systems that use ultra-short electrical pulses to destroy unwanted tissue in the body, with applications ranging from skin conditions to heart rhythm disorders. Its product line includes tools for use in both surgical and clinical settings, giving physicians flexible options for different treatment needs.

Key Fundamentals

EPS-1.18
ROE-90.23
RPS0.02
ROIC-519
ROA-76.64
EBITDA, mln-79.03
EV / EBITDA-43.88
EV / EBIT-43.32
Revenue, mln1.18
EV / Revenue2,927

Quote Details

Last 53.02
Change 0.34 (0.65%)
Open 52.44
Volume 451,930
Turnover 23,961,328
Average Volume 431,831

Financial Ratios

Pre-Tax Profit Margin-6,756
Leverage Ratio1.16
Current Ratio9.63
Price / Book35.19
Price / Tangible Book36.49
Debt / Equity0.07
Price / Sales2,919

Financial Strength

Altman Z-Score131
Piotroski F-Score 4 / 9
1-Year Target Price62.33
Short Ratio4.70
Short % of Float15.53

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 19.33% 98 / 100   
1 Month 2.3% 82 / 100   
2 Months 83.08% 99 / 100   
6 Months 130% 99 / 100   
1 Year 207% 99 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog